DANIO-CODE
| Gene Symbol | Gene ID | Gene Info |
|---|---|---|
|
tbx15
|
ENSDARG00000002582 | T-box transcription factor 15 |
|
si_ch211-69l10.4
|
ENSDARG00000098036 | si_ch211-69l10.4 |
|
tbx4
|
ENSDARG00000030058 | T-box transcription factor 4 |
|
tbx1
|
ENSDARG00000031891 | T-box transcription factor 1 |
|
mgaa
|
ENSDARG00000078784 | MAX dimerization protein MGA a |
| Gene | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| mgaa | dr10_dc_chr17_+_10410393_10410496 | 0.75 | 8.5e-04 | Click! |
| tbx1 | dr10_dc_chr5_+_14703190_14703228 | 0.70 | 2.5e-03 | Click! |
| tbx15 | dr10_dc_chr9_-_21257082_21257137 | 0.45 | 8.3e-02 | Click! |
| tbx4 | dr10_dc_chr15_+_27454643_27454665 | 0.40 | 1.2e-01 | Click! |
| Promoter | Score | Transcript | Gene | Gene Info |
|---|---|---|---|---|
| chr23_+_23305483 | 17.53 |
ENSDART00000126479
|
plekhn1
|
pleckstrin homology domain containing, family N member 1 |
| chr1_-_11439671 | 12.63 |
ENSDART00000164817
|
mtp
|
microsomal triglyceride transfer protein |
| chr17_+_26946957 | 9.56 |
ENSDART00000114215
|
grhl3
|
grainyhead-like transcription factor 3 |
| chr17_-_42293039 | 9.47 |
ENSDART00000014296
|
foxa2
|
forkhead box A2 |
| chr21_-_3548719 | 9.33 |
ENSDART00000137844
|
atp8b1
|
ATPase, aminophospholipid transporter, class I, type 8B, member 1 |
| chr5_+_26925238 | 8.43 |
ENSDART00000051491
|
sfrp1a
|
secreted frizzled-related protein 1a |
| chr11_-_11591394 | 7.89 |
ENSDART00000142208
|
zgc:110712
|
zgc:110712 |
| chr7_+_6814828 | 7.38 |
ENSDART00000001649
|
actn3b
|
actinin alpha 3b |
| chr19_-_7501777 | 7.02 |
ENSDART00000081741
|
rab25a
|
RAB25, member RAS oncogene family a |
| chr19_+_14197118 | 6.95 |
ENSDART00000166230
|
tpbga
|
trophoblast glycoprotein a |
| chr25_-_10919875 | 6.88 |
ENSDART00000099572
|
mespab
|
mesoderm posterior ab |
| chr14_-_5510157 | 6.48 |
ENSDART00000131820
|
kazald2
|
Kazal-type serine peptidase inhibitor domain 2 |
| chr6_+_56157608 | 6.47 |
ENSDART00000149665
|
tfap2c
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
| chr11_-_11925832 | 6.17 |
|
|
|
| chr14_-_25879853 | 6.15 |
ENSDART00000014149
|
fat2
|
FAT atypical cadherin 2 |
| KN150078v1_+_1387 | 5.79 |
|
|
|
| chr8_-_38168395 | 5.54 |
ENSDART00000155189
|
pdlim2
|
PDZ and LIM domain 2 (mystique) |
| chr3_-_44113070 | 5.23 |
ENSDART00000160717
|
znf750
|
zinc finger protein 750 |
| chr22_-_15567180 | 5.23 |
ENSDART00000123125
|
tpm4a
|
tropomyosin 4a |
| chr16_-_26803204 | 5.21 |
ENSDART00000162665
|
esrp1
|
epithelial splicing regulatory protein 1 |
| chr1_-_51862897 | 5.16 |
ENSDART00000136469
|
acy3.2
|
aspartoacylase (aminocyclase) 3, tandem duplicate 2 |
| chr15_+_42440802 | 5.00 |
ENSDART00000089694
|
tiam1b
|
T-cell lymphoma invasion and metastasis 1b |
| chr25_+_31547276 | 4.98 |
ENSDART00000090727
|
duox
|
dual oxidase |
| chr24_+_19374200 | 4.91 |
ENSDART00000056081
ENSDART00000027022 |
sulf1
|
sulfatase 1 |
| chr8_-_22486746 | 4.67 |
ENSDART00000101616
|
si:ch211-261n11.5
|
si:ch211-261n11.5 |
| chr24_+_19374099 | 4.45 |
ENSDART00000056081
ENSDART00000027022 |
sulf1
|
sulfatase 1 |
| chr2_-_53772219 | 4.31 |
ENSDART00000037557
|
admp
|
anti-dorsalizing morphogenic protein |
| chr15_+_42440952 | 4.27 |
ENSDART00000089694
|
tiam1b
|
T-cell lymphoma invasion and metastasis 1b |
| chr23_-_39956151 | 4.26 |
ENSDART00000115330
|
ppp1r14c
|
protein phosphatase 1, regulatory (inhibitor) subunit 14C |
| chr7_+_15065241 | 4.24 |
ENSDART00000045385
|
mespba
|
mesoderm posterior ba |
| chr4_+_9027862 | 4.23 |
ENSDART00000102893
|
aldh1l2
|
aldehyde dehydrogenase 1 family, member L2 |
| chr20_+_17840364 | 4.22 |
ENSDART00000024627
|
cdh2
|
cadherin 2, type 1, N-cadherin (neuronal) |
| chr7_+_15081529 | 4.21 |
ENSDART00000006018
|
mespaa
|
mesoderm posterior aa |
| chr8_-_14142049 | 4.18 |
ENSDART00000126432
|
rhoaa
|
ras homolog gene family, member Aa |
| chr14_+_46419051 | 4.09 |
ENSDART00000112377
|
map1lc3cl
|
microtubule-associated protein 1 light chain 3 gamma, like |
| chr3_-_60973097 | 4.02 |
ENSDART00000055062
|
pvalb1
|
parvalbumin 1 |
| chr6_+_17959219 | 3.96 |
ENSDART00000026448
|
evpla
|
envoplakin a |
| chr14_+_15698814 | 3.80 |
|
|
|
| chr3_+_13043951 | 3.77 |
|
|
|
| chr13_+_14845093 | 3.77 |
ENSDART00000011520
|
noto
|
notochord homeobox |
| chr14_-_5510256 | 3.77 |
ENSDART00000131820
|
kazald2
|
Kazal-type serine peptidase inhibitor domain 2 |
| chr24_-_18775146 | 3.76 |
ENSDART00000144244
|
cpa6
|
carboxypeptidase A6 |
| chr15_-_20297270 | 3.74 |
ENSDART00000123910
|
ppp1r14ab
|
protein phosphatase 1, regulatory (inhibitor) subunit 14Ab |
| chr7_-_52142689 | 3.71 |
ENSDART00000110265
|
myzap
|
myocardial zonula adherens protein |
| chr4_-_11582061 | 3.62 |
ENSDART00000049066
|
net1
|
neuroepithelial cell transforming 1 |
| chr8_-_4451417 | 3.58 |
ENSDART00000141915
|
si:ch211-166a6.5
|
si:ch211-166a6.5 |
| chr3_-_23513177 | 3.55 |
ENSDART00000078425
|
eve1
|
even-skipped-like1 |
| chr14_-_32404076 | 3.52 |
ENSDART00000075617
|
sox3
|
SRY (sex determining region Y)-box 3 |
| chr25_+_7660590 | 3.51 |
ENSDART00000155016
|
dgkzb
|
diacylglycerol kinase, zeta b |
| chr7_-_58523645 | 3.51 |
|
|
|
| chr2_-_47578695 | 3.36 |
ENSDART00000014350
ENSDART00000038828 |
pax3a
|
paired box 3a |
| chr20_-_43826667 | 3.30 |
ENSDART00000100637
|
mixl1
|
Mix paired-like homeobox |
| chr14_-_6901415 | 3.27 |
ENSDART00000167994
ENSDART00000166532 |
stox2b
|
storkhead box 2b |
| chr7_-_44332679 | 3.26 |
ENSDART00000073745
|
cmtm4
|
CKLF-like MARVEL transmembrane domain containing 4 |
| chr3_-_25683205 | 3.24 |
ENSDART00000169706
|
ntn1b
|
netrin 1b |
| chr23_+_28656263 | 3.24 |
ENSDART00000020296
|
nadl1.2
|
neural adhesion molecule L1.2 |
| chr3_+_42380497 | 3.20 |
ENSDART00000163579
|
si:dkey-43p13.5
|
si:dkey-43p13.5 |
| chr6_+_30441419 | 3.17 |
|
|
|
| chr25_-_31547164 | 3.11 |
ENSDART00000110180
|
duox2
|
dual oxidase 2 |
| chr20_-_19646761 | 3.08 |
|
|
|
| chr22_-_3134876 | 3.08 |
ENSDART00000159580
|
lmnb2
|
lamin B2 |
| chr10_-_26468280 | 3.05 |
ENSDART00000128894
|
dchs1b
|
dachsous cadherin-related 1b |
| chr10_-_44619155 | 3.02 |
ENSDART00000085556
|
hip1ra
|
huntingtin interacting protein 1 related a |
| chr5_+_37053530 | 3.00 |
ENSDART00000161051
|
sptbn2
|
spectrin, beta, non-erythrocytic 2 |
| chr19_-_35642440 | 2.99 |
ENSDART00000167853
ENSDART00000054274 |
macf1a
|
microtubule-actin crosslinking factor 1a |
| chr17_+_1058137 | 2.95 |
|
|
|
| chr17_+_16067769 | 2.95 |
ENSDART00000155292
|
si:ch73-204p21.2
|
si:ch73-204p21.2 |
| chr22_+_1283662 | 2.93 |
ENSDART00000124161
|
si:ch73-138e16.5
|
si:ch73-138e16.5 |
| chr15_-_30975632 | 2.88 |
|
|
|
| chr22_-_37468331 | 2.85 |
ENSDART00000160940
|
SOX2OT_exon1
|
SOX2 overlapping transcript exon 1 |
| chr18_+_7632469 | 2.81 |
ENSDART00000136313
|
si:dkeyp-1h4.6
|
si:dkeyp-1h4.6 |
| chr17_-_42292997 | 2.78 |
ENSDART00000014296
|
foxa2
|
forkhead box A2 |
| KN150214v1_-_155944 | 2.76 |
|
|
|
| chr3_-_19050721 | 2.75 |
ENSDART00000131503
|
rfx1a
|
regulatory factor X, 1a (influences HLA class II expression) |
| chr13_-_33696425 | 2.73 |
ENSDART00000143703
|
flrt3
|
fibronectin leucine rich transmembrane 3 |
| chr15_-_1625846 | 2.66 |
ENSDART00000081875
|
nnr
|
nanor |
| chr11_-_1409262 | 2.65 |
ENSDART00000155269
|
phactr3b
|
phosphatase and actin regulator 3b |
| chr9_-_22140954 | 2.57 |
ENSDART00000146528
|
lmo7a
|
LIM domain 7a |
| chr19_-_23037220 | 2.55 |
ENSDART00000090669
|
pleca
|
plectin a |
| chr13_+_27102308 | 2.55 |
ENSDART00000145901
|
rin2
|
Ras and Rab interactor 2 |
| chr25_-_10930008 | 2.49 |
ENSDART00000156846
|
mespbb
|
mesoderm posterior bb |
| chr13_+_32013916 | 2.46 |
ENSDART00000020270
|
osr1
|
odd-skipped related transciption factor 1 |
| chr15_+_32853646 | 2.38 |
ENSDART00000167515
|
postnb
|
periostin, osteoblast specific factor b |
| chr22_-_120677 | 2.37 |
|
|
|
| chr8_+_32604349 | 2.37 |
ENSDART00000126833
|
hmcn2
|
hemicentin 2 |
| chr13_+_32894285 | 2.30 |
ENSDART00000057377
|
arg2
|
arginase 2 |
| chr14_-_2728708 | 2.30 |
ENSDART00000031211
|
bicc2
|
bicaudal C homolog 2 |
| chr13_+_22165699 | 2.25 |
|
|
|
| chr17_-_31147256 | 2.24 |
ENSDART00000055754
|
pkdccb
|
protein kinase domain containing, cytoplasmic b |
| chr14_+_5078937 | 2.22 |
ENSDART00000031508
|
lbx2
|
ladybird homeobox 2 |
| chr13_+_18401965 | 2.17 |
ENSDART00000136024
|
ftr14l
|
finTRIM family, member 14-like |
| chr10_-_43711606 | 2.14 |
ENSDART00000170891
|
si:ch73-215f7.1
|
si:ch73-215f7.1 |
| chr22_-_4414254 | 2.12 |
ENSDART00000114465
|
zgc:195170
|
zgc:195170 |
| chr2_+_20118917 | 2.11 |
ENSDART00000038648
|
ptbp2b
|
polypyrimidine tract binding protein 2b |
| chr12_-_34786844 | 2.11 |
ENSDART00000027379
|
bicral
|
BRD4 interacting chromatin remodeling complex associated protein like |
| chr23_+_20522512 | 2.10 |
ENSDART00000137294
|
slc35c2
|
solute carrier family 35 (GDP-fucose transporter), member C2 |
| chr1_+_50835265 | 2.09 |
ENSDART00000162226
|
meis1a
|
Meis homeobox 1 a |
| chr12_-_43917936 | 2.09 |
ENSDART00000159423
|
foxi1
|
forkhead box i1 |
| chr13_+_27102377 | 2.08 |
ENSDART00000138043
|
rin2
|
Ras and Rab interactor 2 |
| chr1_-_51863187 | 2.07 |
ENSDART00000004233
|
acy3.2
|
aspartoacylase (aminocyclase) 3, tandem duplicate 2 |
| chr11_+_23695123 | 2.00 |
ENSDART00000000486
|
cntn2
|
contactin 2 |
| chr4_+_899111 | 1.98 |
ENSDART00000103631
|
ripply2
|
ripply transcriptional repressor 2 |
| chr2_-_42384993 | 1.92 |
ENSDART00000141358
|
apom
|
apolipoprotein M |
| chr9_+_33167554 | 1.88 |
ENSDART00000007630
|
nhlh2
|
nescient helix loop helix 2 |
| chr13_+_22350043 | 1.88 |
ENSDART00000136863
|
ldb3a
|
LIM domain binding 3a |
| chr19_-_791149 | 1.86 |
ENSDART00000151782
ENSDART00000037515 |
msto1
|
misato 1, mitochondrial distribution and morphology regulator |
| chr24_-_32750010 | 1.85 |
ENSDART00000038364
|
ca2
|
carbonic anhydrase II |
| chr16_-_26803131 | 1.85 |
ENSDART00000103431
|
esrp1
|
epithelial splicing regulatory protein 1 |
| chr16_+_40351223 | 1.84 |
ENSDART00000058578
|
rspo3
|
R-spondin 3 |
| chr12_-_31342432 | 1.83 |
ENSDART00000148603
|
acsl5
|
acyl-CoA synthetase long-chain family member 5 |
| chr4_-_19027117 | 1.80 |
ENSDART00000166160
|
si:dkey-31f5.11
|
si:dkey-31f5.11 |
| chr19_-_32175977 | 1.80 |
|
|
|
| chr10_+_18994733 | 1.79 |
ENSDART00000146517
|
dpysl2b
|
dihydropyrimidinase-like 2b |
| chr19_+_47720261 | 1.74 |
ENSDART00000136647
|
ext1c
|
exostoses (multiple) 1c |
| chr13_+_22165657 | 1.74 |
|
|
|
| chr20_-_54645287 | 1.74 |
ENSDART00000153389
|
yy1b
|
YY1 transcription factor b |
| chr7_-_18256512 | 1.71 |
ENSDART00000173539
|
rgs12a
|
regulator of G protein signaling 12a |
| chr3_+_43010408 | 1.71 |
ENSDART00000169061
|
CU138533.1
|
ENSDARG00000099842 |
| chr17_-_8155740 | 1.71 |
ENSDART00000064678
|
lft2
|
lefty2 |
| chr11_-_30105047 | 1.64 |
ENSDART00000030794
|
tmem169a
|
transmembrane protein 169a |
| chr6_-_3763870 | 1.62 |
ENSDART00000171804
|
tlk1b
|
tousled-like kinase 1b |
| chr1_-_18695214 | 1.62 |
|
|
|
| chr19_+_14197020 | 1.61 |
ENSDART00000166230
|
tpbga
|
trophoblast glycoprotein a |
| chr13_-_36409205 | 1.61 |
ENSDART00000043312
|
srsf5a
|
serine/arginine-rich splicing factor 5a |
| chr25_-_12691849 | 1.59 |
ENSDART00000158551
|
slc7a5
|
solute carrier family 7 (amino acid transporter light chain, L system), member 5 |
| chr17_-_10682357 | 1.54 |
ENSDART00000064597
|
lgals3b
|
lectin, galactoside binding soluble 3b |
| chr9_-_22141138 | 1.54 |
ENSDART00000146528
|
lmo7a
|
LIM domain 7a |
| chr10_-_4979688 | 1.52 |
ENSDART00000093228
|
mat2al
|
methionine adenosyltransferase II, alpha-like |
| chr20_-_8122838 | 1.49 |
ENSDART00000113993
|
si:ch211-232i5.1
|
si:ch211-232i5.1 |
| chr17_-_20264762 | 1.49 |
|
|
|
| chr7_+_29969936 | 1.48 |
ENSDART00000109243
|
sema4bb
|
sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4Bb |
| chr13_+_30190977 | 1.47 |
|
|
|
| chr17_+_38307512 | 1.45 |
ENSDART00000005296
|
nkx2.9
|
NK2 transcription factor related, locus 9 (Drosophila) |
| chr8_-_6875110 | 1.45 |
ENSDART00000014915
|
asb6
|
ankyrin repeat and SOCS box containing 6 |
| chr23_+_22763861 | 1.41 |
|
|
|
| chr16_-_29502741 | 1.40 |
ENSDART00000148405
|
si:ch211-113g11.6
|
si:ch211-113g11.6 |
| chr10_+_4717800 | 1.40 |
ENSDART00000161789
|
palm2
|
paralemmin 2 |
| chr15_-_104331 | 1.39 |
ENSDART00000164323
ENSDART00000161218 |
cyp2y3
|
cytochrome P450, family 2, subfamily Y, polypeptide 3 |
| chr12_+_25509394 | 1.39 |
ENSDART00000077157
|
six3b
|
SIX homeobox 3b |
| chr13_+_32894092 | 1.38 |
ENSDART00000057377
|
arg2
|
arginase 2 |
| chr11_+_23694891 | 1.38 |
ENSDART00000000486
|
cntn2
|
contactin 2 |
| chr25_-_31218193 | 1.38 |
ENSDART00000170673
ENSDART00000166930 |
lamb1a
|
laminin, beta 1a |
| chr16_-_41553835 | 1.37 |
ENSDART00000029492
|
cmtm7
|
CKLF-like MARVEL transmembrane domain containing 7 |
| chr11_-_26595578 | 1.37 |
ENSDART00000153519
|
iqsec1b
|
IQ motif and Sec7 domain 1b |
| chr22_-_12130441 | 1.36 |
ENSDART00000146785
|
tmem163b
|
transmembrane protein 163b |
| chr21_+_25729090 | 1.35 |
ENSDART00000021664
|
cldnb
|
claudin b |
| chr15_+_40707917 | 1.33 |
ENSDART00000154187
ENSDART00000042082 |
fat3a
|
FAT atypical cadherin 3a |
| chr23_-_24240728 | 1.33 |
ENSDART00000113598
|
arhgef19
|
Rho guanine nucleotide exchange factor (GEF) 19 |
| chr5_-_44243476 | 1.33 |
ENSDART00000161408
|
fbp1a
|
fructose-1,6-bisphosphatase 1a |
| chr10_-_31838886 | 1.31 |
ENSDART00000128839
|
fez1
|
fasciculation and elongation protein zeta 1 (zygin I) |
| chr8_-_28415750 | 1.31 |
ENSDART00000062702
|
cebpb
|
CCAAT/enhancer binding protein (C/EBP), beta |
| chr9_-_43072092 | 1.27 |
ENSDART00000125953
|
ttn.1
|
titin, tandem duplicate 1 |
| chr24_-_6129575 | 1.26 |
ENSDART00000021609
|
gad2
|
glutamate decarboxylase 2 |
| chr19_-_5416317 | 1.26 |
ENSDART00000010373
|
krt1-19d
|
keratin, type 1, gene 19d |
| chr5_+_51992974 | 1.25 |
ENSDART00000170341
|
apba1a
|
amyloid beta (A4) precursor protein-binding, family A, member 1a |
| chr20_+_316191 | 1.25 |
ENSDART00000104807
|
si:dkey-119m7.4
|
si:dkey-119m7.4 |
| chr10_-_43711513 | 1.25 |
ENSDART00000170891
|
si:ch73-215f7.1
|
si:ch73-215f7.1 |
| chr12_+_29121368 | 1.22 |
ENSDART00000006505
|
mxtx2
|
mix-type homeobox gene 2 |
| chr25_+_7147666 | 1.22 |
ENSDART00000104712
|
hmg20a
|
high mobility group 20A |
| chr22_+_16471319 | 1.22 |
ENSDART00000014330
|
ier5
|
immediate early response 5 |
| chr3_+_34010958 | 1.21 |
ENSDART00000131802
|
si:dkey-204f11.64
|
si:dkey-204f11.64 |
| chr17_-_15490279 | 1.20 |
ENSDART00000156905
ENSDART00000161374 ENSDART00000080661 |
si:ch211-266g18.10
|
si:ch211-266g18.10 |
| chr15_-_41288480 | 1.20 |
ENSDART00000155359
|
smco4
|
single-pass membrane protein with coiled-coil domains 4 |
| chr5_+_34022151 | 1.19 |
ENSDART00000141338
|
enc1
|
ectodermal-neural cortex 1 |
| chr14_-_32704626 | 1.18 |
ENSDART00000170626
|
kdrl
|
kinase insert domain receptor like |
| chr2_+_56946287 | 1.17 |
|
|
|
| chr19_-_5851328 | 1.15 |
ENSDART00000133106
|
si:ch211-264f5.6
|
si:ch211-264f5.6 |
| chr14_+_33382973 | 1.14 |
ENSDART00000132488
|
apln
|
apelin |
| chr2_+_56946090 | 1.14 |
|
|
|
| chr22_-_14103803 | 1.13 |
ENSDART00000062902
|
ENSDARG00000042857
|
ENSDARG00000042857 |
| chr25_-_32344881 | 1.12 |
ENSDART00000012862
|
isl2a
|
ISL LIM homeobox 2a |
| chr9_+_17431036 | 1.11 |
ENSDART00000140852
|
rgcc
|
regulator of cell cycle |
| chr6_+_30447235 | 1.11 |
|
|
|
| chr20_-_47576935 | 1.10 |
ENSDART00000067776
|
rab10
|
RAB10, member RAS oncogene family |
| chr8_-_19166630 | 1.09 |
|
|
|
| chr1_+_36476280 | 1.08 |
ENSDART00000043855
|
dclk2a
|
doublecortin-like kinase 2a |
| chr10_-_31619761 | 1.06 |
ENSDART00000023575
|
robo3
|
roundabout, axon guidance receptor, homolog 3 (Drosophila) |
| chr21_-_2191847 | 1.06 |
ENSDART00000159315
|
si:dkey-50i6.5
|
si:dkey-50i6.5 |
| chr23_+_23559246 | 1.06 |
ENSDART00000172214
|
agrn
|
agrin |
| chr11_-_6051096 | 1.04 |
ENSDART00000147761
|
vsg1
|
vessel-specific 1 |
| chr16_+_46728964 | 1.03 |
ENSDART00000163571
|
rab25b
|
RAB25, member RAS oncogene family b |
| chr10_-_44619365 | 1.03 |
ENSDART00000085556
|
hip1ra
|
huntingtin interacting protein 1 related a |
| chr18_+_18874077 | 1.03 |
ENSDART00000091094
|
pllp
|
plasmolipin |
| chr22_-_30986222 | 1.03 |
ENSDART00000133335
|
si:dkey-49n23.1
|
si:dkey-49n23.1 |
| chr11_+_1601946 | 1.03 |
ENSDART00000154967
|
lrp1aa
|
low density lipoprotein receptor-related protein 1Aa |
| chr2_-_53771952 | 1.02 |
ENSDART00000037557
|
admp
|
anti-dorsalizing morphogenic protein |
| chr7_+_32097831 | 1.01 |
ENSDART00000169588
|
LGR4
|
leucine rich repeat containing G protein-coupled receptor 4 |
| chr20_-_23949621 | 1.01 |
|
|
|
| chr1_-_8968543 | 1.00 |
ENSDART00000126877
ENSDART00000123773 ENSDART00000126996 |
ugt5b1
ugt5b3
|
UDP glucuronosyltransferase 5 family, polypeptide B1 UDP glucuronosyltransferase 5 family, polypeptide B3 |
| chr21_+_26690161 | 0.99 |
ENSDART00000065392
|
calm3b
|
calmodulin 3b (phosphorylase kinase, delta) |
| chr8_+_20125687 | 0.99 |
ENSDART00000124809
|
acsbg2
|
acyl-CoA synthetase bubblegum family member 2 |
| chr25_-_17483202 | 0.99 |
ENSDART00000073684
|
mmp15a
|
matrix metallopeptidase 15a |
| chr17_-_38494727 | 0.98 |
ENSDART00000085438
|
rps6ka5
|
ribosomal protein S6 kinase, polypeptide 5 |
| chr25_+_35777308 | 0.97 |
ENSDART00000073452
|
si:ch211-113a14.12
|
si:ch211-113a14.12 |
| chr17_+_31722419 | 0.96 |
ENSDART00000155073
|
arhgap5
|
Rho GTPase activating protein 5 |
| chr15_-_23711689 | 0.96 |
ENSDART00000128644
|
ckmb
|
creatine kinase, muscle b |
| chr7_+_60054116 | 0.96 |
ENSDART00000145201
|
ppp1r14bb
|
protein phosphatase 1, regulatory (inhibitor) subunit 14Bb |
| chr15_-_37973812 | 0.95 |
ENSDART00000122439
|
si:dkey-238d18.4
|
si:dkey-238d18.4 |
| chr11_+_27970922 | 0.95 |
ENSDART00000169360
ENSDART00000043756 |
ephb2b
|
eph receptor B2b |
| chr3_-_23539034 | 0.94 |
|
|
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 4.4 | 17.6 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
| 2.7 | 10.9 | GO:0097101 | blood vessel endothelial cell fate specification(GO:0097101) |
| 2.7 | 5.3 | GO:0060063 | Spemann organizer formation at the embryonic shield(GO:0060063) |
| 2.6 | 13.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
| 2.3 | 9.4 | GO:0021910 | smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021910) |
| 1.9 | 3.8 | GO:0048322 | axial mesodermal cell differentiation(GO:0048321) axial mesodermal cell fate commitment(GO:0048322) axial mesodermal cell fate specification(GO:0048327) |
| 1.7 | 10.4 | GO:0060829 | negative regulation of canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060829) |
| 1.7 | 5.0 | GO:0042554 | superoxide anion generation(GO:0042554) |
| 1.4 | 4.2 | GO:0001502 | cartilage condensation(GO:0001502) cell aggregation(GO:0098743) |
| 1.3 | 3.8 | GO:0060832 | oocyte animal/vegetal axis specification(GO:0060832) |
| 1.1 | 10.2 | GO:0060325 | face morphogenesis(GO:0060325) |
| 0.9 | 3.7 | GO:0000050 | urea cycle(GO:0000050) urea metabolic process(GO:0019627) |
| 0.8 | 3.4 | GO:0048677 | axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.8 | 4.2 | GO:1902766 | skeletal muscle satellite cell migration(GO:1902766) |
| 0.8 | 8.9 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
| 0.8 | 2.4 | GO:0043589 | skin morphogenesis(GO:0043589) |
| 0.7 | 2.2 | GO:1904105 | positive regulation of convergent extension involved in gastrulation(GO:1904105) |
| 0.7 | 3.6 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
| 0.7 | 2.1 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
| 0.6 | 3.2 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
| 0.6 | 2.5 | GO:0035776 | pronephric proximal tubule development(GO:0035776) |
| 0.6 | 1.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.6 | 1.8 | GO:1902001 | regulation of plasma membrane long-chain fatty acid transport(GO:0010746) positive regulation of plasma membrane long-chain fatty acid transport(GO:0010747) plasma membrane long-chain fatty acid transport(GO:0015911) regulation of organic acid transport(GO:0032890) positive regulation of organic acid transport(GO:0032892) fatty acid transmembrane transport(GO:1902001) positive regulation of anion transport(GO:1903793) regulation of anion transmembrane transport(GO:1903959) positive regulation of anion transmembrane transport(GO:1903961) regulation of fatty acid transport(GO:2000191) positive regulation of fatty acid transport(GO:2000193) |
| 0.6 | 4.2 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
| 0.5 | 1.5 | GO:0048245 | eosinophil chemotaxis(GO:0048245) eosinophil migration(GO:0072677) |
| 0.5 | 3.1 | GO:0007343 | egg activation(GO:0007343) |
| 0.5 | 1.9 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.5 | 0.5 | GO:0006531 | aspartate metabolic process(GO:0006531) |
| 0.5 | 1.4 | GO:0055016 | hypochord development(GO:0055016) |
| 0.4 | 6.5 | GO:0014036 | neural crest cell fate commitment(GO:0014034) neural crest cell fate specification(GO:0014036) |
| 0.4 | 1.3 | GO:1902571 | regulation of serine-type peptidase activity(GO:1902571) |
| 0.4 | 4.0 | GO:0042661 | regulation of mesodermal cell fate specification(GO:0042661) |
| 0.4 | 3.5 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
| 0.4 | 1.1 | GO:0042756 | drinking behavior(GO:0042756) |
| 0.4 | 3.4 | GO:0050936 | xanthophore differentiation(GO:0050936) |
| 0.3 | 9.4 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
| 0.3 | 1.3 | GO:0009448 | gamma-aminobutyric acid metabolic process(GO:0009448) |
| 0.3 | 10.4 | GO:0050772 | positive regulation of axonogenesis(GO:0050772) |
| 0.3 | 4.4 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.3 | 4.1 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.3 | 1.1 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
| 0.3 | 0.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 0.3 | 0.8 | GO:0030818 | negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclic nucleotide metabolic process(GO:0030800) negative regulation of cyclic nucleotide biosynthetic process(GO:0030803) negative regulation of nucleotide biosynthetic process(GO:0030809) negative regulation of cAMP metabolic process(GO:0030815) negative regulation of cAMP biosynthetic process(GO:0030818) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) negative regulation of purine nucleotide biosynthetic process(GO:1900372) |
| 0.3 | 3.3 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.2 | 1.1 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
| 0.2 | 1.7 | GO:0070328 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
| 0.2 | 4.5 | GO:0055003 | cardiac myofibril assembly(GO:0055003) |
| 0.2 | 4.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
| 0.2 | 0.6 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
| 0.2 | 0.4 | GO:0051965 | regulation of synapse assembly(GO:0051963) positive regulation of synapse assembly(GO:0051965) |
| 0.2 | 1.3 | GO:0048769 | sarcomerogenesis(GO:0048769) |
| 0.2 | 4.0 | GO:0045104 | intermediate filament-based process(GO:0045103) intermediate filament cytoskeleton organization(GO:0045104) |
| 0.2 | 0.7 | GO:0070296 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0014808) sarcoplasmic reticulum calcium ion transport(GO:0070296) calcium ion transport from endoplasmic reticulum to cytosol(GO:1903514) |
| 0.2 | 0.5 | GO:1903385 | dendrite guidance(GO:0070983) regulation of homophilic cell adhesion(GO:1903385) |
| 0.2 | 0.8 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
| 0.2 | 0.8 | GO:0099640 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) anterograde dendritic transport of neurotransmitter receptor complex(GO:0098971) axo-dendritic protein transport(GO:0099640) |
| 0.2 | 1.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) |
| 0.2 | 1.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
| 0.1 | 0.7 | GO:0033292 | T-tubule organization(GO:0033292) |
| 0.1 | 4.8 | GO:0048484 | enteric nervous system development(GO:0048484) |
| 0.1 | 1.8 | GO:0016203 | muscle attachment(GO:0016203) |
| 0.1 | 1.0 | GO:0016572 | histone phosphorylation(GO:0016572) |
| 0.1 | 14.4 | GO:0001558 | regulation of cell growth(GO:0001558) |
| 0.1 | 0.8 | GO:0090303 | positive regulation of wound healing(GO:0090303) |
| 0.1 | 1.7 | GO:0003128 | heart field specification(GO:0003128) specification of organ identity(GO:0010092) |
| 0.1 | 0.8 | GO:0030104 | water homeostasis(GO:0030104) |
| 0.1 | 3.5 | GO:0043049 | otic placode formation(GO:0043049) |
| 0.1 | 1.0 | GO:0006603 | phosphagen metabolic process(GO:0006599) phosphocreatine metabolic process(GO:0006603) phosphagen biosynthetic process(GO:0042396) phosphocreatine biosynthetic process(GO:0046314) |
| 0.1 | 0.6 | GO:1900028 | negative regulation of Rac protein signal transduction(GO:0035021) wound healing, spreading of epidermal cells(GO:0035313) negative regulation of ruffle assembly(GO:1900028) |
| 0.1 | 0.7 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
| 0.1 | 0.1 | GO:0048320 | axial mesoderm formation(GO:0048320) |
| 0.1 | 0.9 | GO:0042694 | muscle cell fate specification(GO:0042694) |
| 0.1 | 2.3 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
| 0.1 | 1.3 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 | 0.8 | GO:0070199 | establishment of protein localization to chromosome(GO:0070199) establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 0.9 | GO:0086003 | cardiac muscle cell contraction(GO:0086003) |
| 0.1 | 1.2 | GO:0021683 | cerebellar granular layer development(GO:0021681) cerebellar granular layer morphogenesis(GO:0021683) cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
| 0.1 | 1.2 | GO:0030878 | thyroid gland development(GO:0030878) |
| 0.1 | 1.4 | GO:0021631 | optic nerve morphogenesis(GO:0021631) |
| 0.1 | 0.6 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.6 | GO:0072378 | platelet aggregation(GO:0070527) blood coagulation, fibrin clot formation(GO:0072378) |
| 0.1 | 0.3 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.1 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
| 0.1 | 0.4 | GO:0070309 | lens fiber cell development(GO:0070307) lens fiber cell morphogenesis(GO:0070309) |
| 0.1 | 0.5 | GO:0033138 | positive regulation of peptidyl-serine phosphorylation(GO:0033138) |
| 0.1 | 3.1 | GO:0030834 | regulation of actin filament depolymerization(GO:0030834) negative regulation of actin filament depolymerization(GO:0030835) actin filament capping(GO:0051693) |
| 0.1 | 0.6 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.1 | 0.2 | GO:0098900 | regulation of action potential(GO:0098900) |
| 0.1 | 1.0 | GO:0044243 | collagen catabolic process(GO:0030574) multicellular organism catabolic process(GO:0044243) |
| 0.1 | 0.4 | GO:0030033 | microvillus assembly(GO:0030033) microvillus organization(GO:0032528) |
| 0.1 | 0.3 | GO:0007525 | somatic muscle development(GO:0007525) |
| 0.1 | 1.6 | GO:0021514 | ventral spinal cord interneuron differentiation(GO:0021514) |
| 0.1 | 0.9 | GO:0044030 | regulation of DNA methylation(GO:0044030) |
| 0.1 | 0.4 | GO:2000576 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
| 0.1 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
| 0.1 | 6.6 | GO:0008544 | epidermis development(GO:0008544) |
| 0.1 | 1.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
| 0.1 | 0.3 | GO:0048041 | cell-substrate adherens junction assembly(GO:0007045) focal adhesion assembly(GO:0048041) regulation of focal adhesion assembly(GO:0051893) regulation of cell-substrate junction assembly(GO:0090109) |
| 0.1 | 0.3 | GO:0051177 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) meiotic sister chromatid cohesion, centromeric(GO:0051754) |
| 0.1 | 0.4 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.1 | 0.3 | GO:2000379 | protein import into mitochondrial inner membrane(GO:0045039) positive regulation of reactive oxygen species metabolic process(GO:2000379) |
| 0.1 | 0.3 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
| 0.1 | 1.7 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 | 0.3 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
| 0.1 | 0.2 | GO:0090242 | mesodermal-endodermal cell signaling(GO:0003131) response to vitamin A(GO:0033189) cellular response to vitamin A(GO:0071299) retinoic acid receptor signaling pathway involved in somitogenesis(GO:0090242) |
| 0.1 | 0.7 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.1 | 0.6 | GO:0043687 | post-translational protein modification(GO:0043687) |
| 0.1 | 0.9 | GO:0006942 | regulation of striated muscle contraction(GO:0006942) |
| 0.0 | 0.6 | GO:0045332 | phospholipid translocation(GO:0045332) |
| 0.0 | 5.3 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
| 0.0 | 0.6 | GO:0033627 | cell adhesion mediated by integrin(GO:0033627) |
| 0.0 | 0.3 | GO:0003207 | cardiac chamber formation(GO:0003207) |
| 0.0 | 1.0 | GO:0006829 | zinc II ion transport(GO:0006829) |
| 0.0 | 0.7 | GO:0071696 | ectodermal placode development(GO:0071696) |
| 0.0 | 0.9 | GO:0097581 | lamellipodium assembly(GO:0030032) lamellipodium organization(GO:0097581) |
| 0.0 | 0.4 | GO:0031577 | mitotic spindle assembly checkpoint(GO:0007094) spindle checkpoint(GO:0031577) negative regulation of mitotic metaphase/anaphase transition(GO:0045841) spindle assembly checkpoint(GO:0071173) mitotic spindle checkpoint(GO:0071174) |
| 0.0 | 0.3 | GO:0060061 | developmental induction(GO:0031128) Spemann organizer formation(GO:0060061) |
| 0.0 | 0.8 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.0 | 1.8 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.2 | GO:0007198 | adenylate cyclase-inhibiting serotonin receptor signaling pathway(GO:0007198) |
| 0.0 | 1.0 | GO:0017144 | drug metabolic process(GO:0017144) drug catabolic process(GO:0042737) exogenous drug catabolic process(GO:0042738) |
| 0.0 | 0.3 | GO:0070650 | actin filament bundle distribution(GO:0070650) |
| 0.0 | 6.0 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.2 | GO:0099565 | chemical synaptic transmission, postsynaptic(GO:0099565) |
| 0.0 | 0.8 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.0 | 0.4 | GO:0048922 | posterior lateral line neuromast deposition(GO:0048922) |
| 0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) estrogen metabolic process(GO:0008210) |
| 0.0 | 0.3 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
| 0.0 | 0.7 | GO:0003323 | type B pancreatic cell development(GO:0003323) |
| 0.0 | 0.9 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.0 | 1.1 | GO:0048546 | digestive tract morphogenesis(GO:0048546) |
| 0.0 | 2.3 | GO:0031101 | fin regeneration(GO:0031101) |
| 0.0 | 0.2 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
| 0.0 | 0.6 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.0 | 0.8 | GO:0060349 | bone morphogenesis(GO:0060349) |
| 0.0 | 0.1 | GO:0021846 | cell proliferation in forebrain(GO:0021846) |
| 0.0 | 0.9 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 2.1 | GO:0008284 | positive regulation of cell proliferation(GO:0008284) |
| 0.0 | 0.8 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.0 | 2.4 | GO:0060047 | heart contraction(GO:0060047) |
| 0.0 | 0.3 | GO:0045445 | myoblast differentiation(GO:0045445) |
| 0.0 | 0.2 | GO:0032264 | IMP salvage(GO:0032264) |
| 0.0 | 0.4 | GO:0039021 | pronephric glomerulus development(GO:0039021) |
| 0.0 | 0.3 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.0 | 1.9 | GO:0043062 | extracellular matrix organization(GO:0030198) extracellular structure organization(GO:0043062) |
| 0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.0 | 0.8 | GO:0016358 | dendrite development(GO:0016358) |
| 0.0 | 1.7 | GO:0007519 | skeletal muscle tissue development(GO:0007519) |
| 0.0 | 1.4 | GO:0030155 | regulation of cell adhesion(GO:0030155) |
| 0.0 | 2.2 | GO:0048701 | embryonic cranial skeleton morphogenesis(GO:0048701) |
| 0.0 | 3.3 | GO:0061061 | muscle structure development(GO:0061061) |
| 0.0 | 0.5 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
| 0.0 | 0.2 | GO:0007193 | adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway(GO:0007193) |
| 0.0 | 0.4 | GO:0019722 | calcium-mediated signaling(GO:0019722) |
| 0.0 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) |
| 0.0 | 0.6 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.2 | GO:0008361 | regulation of cell size(GO:0008361) |
| 0.0 | 0.8 | GO:0006865 | amino acid transport(GO:0006865) |
| 0.0 | 0.6 | GO:0001947 | heart looping(GO:0001947) |
| 0.0 | 0.8 | GO:0001666 | response to hypoxia(GO:0001666) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.7 | 5.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 1.3 | 10.3 | GO:0005614 | interstitial matrix(GO:0005614) |
| 0.9 | 3.8 | GO:0032019 | mitochondrial cloud(GO:0032019) |
| 0.6 | 3.0 | GO:0008091 | spectrin(GO:0008091) |
| 0.4 | 4.4 | GO:0030056 | hemidesmosome(GO:0030056) |
| 0.4 | 4.2 | GO:0014704 | intercalated disc(GO:0014704) |
| 0.3 | 1.5 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 7.3 | GO:0031941 | filamentous actin(GO:0031941) |
| 0.2 | 0.8 | GO:0042584 | chromaffin granule membrane(GO:0042584) |
| 0.2 | 0.6 | GO:0005577 | fibrinogen complex(GO:0005577) |
| 0.2 | 4.1 | GO:0000421 | autophagosome membrane(GO:0000421) |
| 0.1 | 9.8 | GO:0005882 | intermediate filament(GO:0005882) |
| 0.1 | 1.4 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 6.4 | GO:0005604 | basement membrane(GO:0005604) |
| 0.1 | 8.5 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.1 | 2.8 | GO:0016342 | catenin complex(GO:0016342) |
| 0.1 | 1.2 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 0.1 | 1.1 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.1 | 0.8 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.1 | 0.9 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.1 | 0.3 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.3 | GO:0016460 | myosin II complex(GO:0016460) |
| 0.1 | 3.6 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 4.5 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 1.5 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.1 | 0.3 | GO:1990130 | Iml1 complex(GO:1990130) |
| 0.1 | 4.2 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 2.9 | GO:0030425 | dendrite(GO:0030425) |
| 0.1 | 0.6 | GO:0097038 | perinuclear endoplasmic reticulum(GO:0097038) |
| 0.1 | 8.4 | GO:0043005 | neuron projection(GO:0043005) |
| 0.1 | 0.4 | GO:0033503 | HULC complex(GO:0033503) |
| 0.1 | 28.9 | GO:0005615 | extracellular space(GO:0005615) |
| 0.1 | 0.2 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
| 0.1 | 0.9 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
| 0.1 | 0.3 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 4.4 | GO:0055037 | recycling endosome(GO:0055037) |
| 0.0 | 0.3 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
| 0.0 | 1.6 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.0 | 5.8 | GO:0005912 | adherens junction(GO:0005912) |
| 0.0 | 2.9 | GO:0070160 | bicellular tight junction(GO:0005923) occluding junction(GO:0070160) |
| 0.0 | 17.0 | GO:0031966 | mitochondrial membrane(GO:0031966) |
| 0.0 | 0.4 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.0 | 0.9 | GO:0005861 | troponin complex(GO:0005861) |
| 0.0 | 0.4 | GO:0098839 | postsynaptic density membrane(GO:0098839) postsynaptic specialization membrane(GO:0099634) |
| 0.0 | 0.6 | GO:0033177 | proton-transporting two-sector ATPase complex, proton-transporting domain(GO:0033177) proton-transporting V-type ATPase, V0 domain(GO:0033179) |
| 0.0 | 0.7 | GO:0044306 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
| 0.0 | 0.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.0 | 0.5 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.0 | 0.7 | GO:0005901 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
| 0.0 | 0.1 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
| 0.0 | 1.5 | GO:0031519 | PcG protein complex(GO:0031519) |
| 0.0 | 0.8 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
| 0.0 | 1.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
| 0.0 | 6.2 | GO:0045202 | synapse(GO:0045202) |
| 0.0 | 0.4 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.0 | 0.2 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.0 | 1.0 | GO:0031012 | extracellular matrix(GO:0031012) |
| 0.0 | 3.5 | GO:0005576 | extracellular region(GO:0005576) |
| 0.0 | 0.4 | GO:0031970 | mitochondrial intermembrane space(GO:0005758) organelle envelope lumen(GO:0031970) |
| 0.0 | 8.2 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.0 | 3.7 | GO:0000785 | chromatin(GO:0000785) |
| 0.0 | 0.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.0 | 0.1 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.9 | 17.6 | GO:1901612 | cardiolipin binding(GO:1901612) |
| 1.7 | 5.0 | GO:0016175 | NAD(P)H oxidase activity(GO:0016174) superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.9 | 9.4 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
| 0.8 | 4.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.8 | 3.0 | GO:0016936 | galactoside binding(GO:0016936) |
| 0.7 | 9.5 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
| 0.7 | 4.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.4 | 1.7 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
| 0.4 | 9.5 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.4 | 4.4 | GO:0030506 | ankyrin binding(GO:0030506) |
| 0.4 | 4.5 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
| 0.4 | 3.5 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.3 | 7.3 | GO:0051393 | muscle alpha-actinin binding(GO:0051371) alpha-actinin binding(GO:0051393) |
| 0.3 | 4.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.3 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.3 | 1.8 | GO:0004157 | dihydropyrimidinase activity(GO:0004157) |
| 0.3 | 1.5 | GO:0004478 | methionine adenosyltransferase activity(GO:0004478) |
| 0.2 | 1.7 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.2 | 0.6 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) protein binding involved in cell-matrix adhesion(GO:0098634) collagen binding involved in cell-matrix adhesion(GO:0098639) |
| 0.2 | 4.7 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
| 0.2 | 0.8 | GO:0099528 | G-protein coupled neurotransmitter receptor activity(GO:0099528) |
| 0.2 | 1.1 | GO:0031704 | apelin receptor binding(GO:0031704) |
| 0.2 | 0.6 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 23.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
| 0.2 | 0.9 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
| 0.2 | 1.8 | GO:0047676 | arachidonate-CoA ligase activity(GO:0047676) |
| 0.2 | 8.4 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.2 | 1.8 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.2 | 0.5 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
| 0.1 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.1 | 7.0 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.1 | 0.3 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.1 | 1.3 | GO:0043236 | laminin binding(GO:0043236) |
| 0.1 | 0.7 | GO:0060182 | apelin receptor activity(GO:0060182) |
| 0.1 | 1.0 | GO:0004111 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
| 0.1 | 0.6 | GO:0015665 | alcohol transmembrane transporter activity(GO:0015665) |
| 0.1 | 0.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.1 | 0.9 | GO:0016316 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) |
| 0.1 | 2.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.1 | 0.7 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
| 0.1 | 0.9 | GO:0030172 | troponin C binding(GO:0030172) troponin I binding(GO:0031013) |
| 0.1 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
| 0.1 | 0.4 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
| 0.1 | 1.0 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 1.2 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 1.0 | GO:0016405 | CoA-ligase activity(GO:0016405) |
| 0.1 | 0.4 | GO:0016842 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) amidine-lyase activity(GO:0016842) |
| 0.1 | 11.9 | GO:0019904 | protein domain specific binding(GO:0019904) |
| 0.1 | 3.3 | GO:0019209 | kinase activator activity(GO:0019209) protein kinase activator activity(GO:0030295) |
| 0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.1 | 0.6 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
| 0.1 | 2.7 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.1 | 0.3 | GO:0032034 | myosin head/neck binding(GO:0032028) myosin II head/neck binding(GO:0032034) myosin II heavy chain binding(GO:0032038) |
| 0.1 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
| 0.1 | 3.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 1.3 | GO:0050308 | carbohydrate phosphatase activity(GO:0019203) sugar-phosphatase activity(GO:0050308) |
| 0.1 | 5.4 | GO:0050839 | cell adhesion molecule binding(GO:0050839) |
| 0.1 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
| 0.1 | 0.3 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.1 | 0.9 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
| 0.1 | 0.7 | GO:0031628 | opioid receptor binding(GO:0031628) |
| 0.1 | 3.3 | GO:0045499 | semaphorin receptor binding(GO:0030215) chemorepellent activity(GO:0045499) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 1.4 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 0.9 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
| 0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.1 | 0.8 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) |
| 0.1 | 5.3 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 3.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
| 0.1 | 0.5 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
| 0.0 | 0.6 | GO:0017046 | peptide hormone binding(GO:0017046) |
| 0.0 | 25.8 | GO:0005509 | calcium ion binding(GO:0005509) |
| 0.0 | 9.2 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
| 0.0 | 0.5 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 0.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
| 0.0 | 0.2 | GO:0043176 | G-protein coupled serotonin receptor activity(GO:0004993) amine binding(GO:0043176) serotonin binding(GO:0051378) serotonin receptor activity(GO:0099589) |
| 0.0 | 0.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
| 0.0 | 0.2 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
| 0.0 | 2.8 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) |
| 0.0 | 15.3 | GO:0046983 | protein dimerization activity(GO:0046983) |
| 0.0 | 0.2 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
| 0.0 | 0.2 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.0 | 2.2 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.0 | 9.7 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
| 0.0 | 0.2 | GO:0008422 | beta-glucosidase activity(GO:0008422) |
| 0.0 | 1.2 | GO:0005179 | hormone activity(GO:0005179) |
| 0.0 | 0.4 | GO:0051959 | dynein intermediate chain binding(GO:0045505) dynein light intermediate chain binding(GO:0051959) |
| 0.0 | 0.2 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
| 0.0 | 0.2 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
| 0.0 | 0.3 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
| 0.0 | 4.8 | GO:0005096 | GTPase activator activity(GO:0005096) |
| 0.0 | 0.6 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
| 0.0 | 1.2 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
| 0.0 | 4.4 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.0 | 0.8 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.0 | 0.1 | GO:0046964 | 3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity(GO:0046964) |
| 0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
| 0.0 | 5.2 | GO:0005198 | structural molecule activity(GO:0005198) |
| 0.0 | 0.5 | GO:0016712 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen(GO:0016712) |
| 0.0 | 0.2 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.0 | 0.8 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.1 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.0 | 0.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.0 | 0.1 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.0 | 0.2 | GO:0008137 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.4 | 13.6 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
| 0.3 | 1.0 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
| 0.2 | 6.1 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
| 0.2 | 6.2 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
| 0.1 | 4.4 | PID ILK PATHWAY | Integrin-linked kinase signaling |
| 0.1 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
| 0.1 | 2.5 | NABA COLLAGENS | Genes encoding collagen proteins |
| 0.1 | 8.3 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.1 | 2.2 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
| 0.1 | 5.5 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
| 0.1 | 2.3 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
| 0.1 | 2.4 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
| 0.1 | 0.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.0 | 1.1 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
| 0.0 | 0.6 | PID RHOA PATHWAY | RhoA signaling pathway |
| 0.0 | 0.8 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
| 0.0 | 0.4 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
| 0.0 | 1.0 | PID P53 REGULATION PATHWAY | p53 pathway |
| 0.0 | 0.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 12.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.5 | 0.9 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
| 0.4 | 3.0 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
| 0.2 | 1.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.2 | 1.8 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
| 0.2 | 4.6 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.2 | 4.0 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
| 0.1 | 1.3 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
| 0.1 | 0.6 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
| 0.1 | 0.6 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
| 0.1 | 2.1 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
| 0.1 | 1.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
| 0.1 | 0.8 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
| 0.1 | 0.2 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
| 0.0 | 0.4 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
| 0.0 | 1.1 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
| 0.0 | 0.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.0 | 0.4 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
| 0.0 | 0.6 | REACTOME TRIGLYCERIDE BIOSYNTHESIS | Genes involved in Triglyceride Biosynthesis |
| 0.0 | 0.4 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
| 0.0 | 0.3 | REACTOME REPAIR SYNTHESIS FOR GAP FILLING BY DNA POL IN TC NER | Genes involved in Repair synthesis for gap-filling by DNA polymerase in TC-NER |
| 0.0 | 0.4 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.0 | 0.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.0 | 0.2 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 1.3 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
| 0.0 | 0.2 | REACTOME FGFR LIGAND BINDING AND ACTIVATION | Genes involved in FGFR ligand binding and activation |
| 0.0 | 0.1 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.0 | 0.6 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.0 | 0.6 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |